Mitochondrial Quality Control Systems in Septic AKI: Molecular Mechanisms and Therapeutic Implications
International Journal of Medical Sciences · 2025
DOI: 10.7150/ijms.107012 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Ying Tan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China. Hauptthemen laut MEDLINE: Acute Kidney Injury, Canagliflozin, Mitochondria, Sepsis. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
- Department of Critical Care Medicine, The First School of Clinical Medicine, Southern Medical University, Guangzhou 510515, China.
- Department of Cardiovascular Surgery, Chinese PLA General Hospital, Beijing 100853, China.
Zitieren
APA
Tan, Y., Ouyang, Y., Ma, Z., Huang, J., Tan, C., Qiu, J., & Wu, F. (2025). Mitochondrial Quality Control Systems in Septic AKI: Molecular Mechanisms and Therapeutic Implications. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.107012
Vancouver
Tan Y, Ouyang Y, Ma Z, Huang J, Tan C, Qiu J, et al. Mitochondrial Quality Control Systems in Septic AKI: Molecular Mechanisms and Therapeutic Implications. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.107012
BibTeX
@article{Tan2025,
author = {Tan, Ying and Ouyang, Yue and Ma, Zisheng and Huang, Jianming and Tan, Chuhong and Qiu, Junxiong and Wu, Feng},
title = {Mitochondrial Quality Control Systems in Septic AKI: Molecular Mechanisms and Therapeutic Implications},
journal = {International Journal of Medical Sciences},
year = {2025},
doi = {10.7150/ijms.107012}
}
EUVIMED